PRS:女性脱发怎么治?植发效果好吗?

2021-04-21 MedSci原创 MedSci原创

女性脱发以不同脱发方式为特征,是一种常见的非瘢痕性脱发。

女性脱发以不同脱发方式为特征,是一种常见的非瘢痕性脱发。 这是一种进行性疾病,从18岁到80岁的任何地方开始,超过35%的女性都会受到影响。来自不同国家的研究表明,20岁至29岁之间的患病率为1%至12%,45 岁以上患者的患病率为12%至56%。 虽然绝经后脱发患病率增加,但仍有大量20岁至45岁的女性需要脱发治疗。与男性相比,女性更难以忍受脱发后的外貌变化,因为大多数人已经习惯了自身茂密的头发,突然大把大把掉头发则会无所适从,难以接受,非常担忧,从而导致生活质量下降。 这种情况对受影响的女性来说非常麻烦,尽管有多种非外科选择,但植发,也就是外科毛囊单位移植仍然是最直接、有效的选择。 该研究对该领域资深作者(C.O.U)的临床资料进行回顾性分析,分享毛囊单位移植治疗女性型脱发的经验和技巧。 图1.用30号针阻断眶上神经和滑车神经,使用左旋布比卡因和利多卡因与1:20万肾上腺素的局麻。 图2.切除2.5厘米宽的椭圆形条带。这是一个毛发切口;切口的上下边缘都是斜面的,两边都有一条1到2毫米的长条,用手术刀加深,以便毛发可以通过切口生长。减张缝合。 图3.“stick-and-place”

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1669068, encodeId=e17b16690689a, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun Jul 25 17:09:19 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012969, encodeId=3d871012969b8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 30 19:57:19 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959367, encodeId=248295936e8b, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e95292076, createdName=148664b9m55暂无昵称, createdTime=Thu Apr 22 13:09:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959366, encodeId=4ebb959366f5, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e95292076, createdName=148664b9m55暂无昵称, createdTime=Thu Apr 22 13:09:31 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047329, encodeId=0539104e3291f, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Apr 21 21:09:19 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
    2021-07-25 kzlchina
  2. [GetPortalCommentsPageByObjectIdResponse(id=1669068, encodeId=e17b16690689a, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun Jul 25 17:09:19 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012969, encodeId=3d871012969b8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 30 19:57:19 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959367, encodeId=248295936e8b, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e95292076, createdName=148664b9m55暂无昵称, createdTime=Thu Apr 22 13:09:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959366, encodeId=4ebb959366f5, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e95292076, createdName=148664b9m55暂无昵称, createdTime=Thu Apr 22 13:09:31 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047329, encodeId=0539104e3291f, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Apr 21 21:09:19 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
    2021-08-30 ms4000001617780766

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1669068, encodeId=e17b16690689a, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun Jul 25 17:09:19 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012969, encodeId=3d871012969b8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 30 19:57:19 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959367, encodeId=248295936e8b, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e95292076, createdName=148664b9m55暂无昵称, createdTime=Thu Apr 22 13:09:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959366, encodeId=4ebb959366f5, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e95292076, createdName=148664b9m55暂无昵称, createdTime=Thu Apr 22 13:09:31 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047329, encodeId=0539104e3291f, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Apr 21 21:09:19 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
    2021-04-22 148664b9m55暂无昵称

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1669068, encodeId=e17b16690689a, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun Jul 25 17:09:19 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012969, encodeId=3d871012969b8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 30 19:57:19 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959367, encodeId=248295936e8b, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e95292076, createdName=148664b9m55暂无昵称, createdTime=Thu Apr 22 13:09:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959366, encodeId=4ebb959366f5, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e95292076, createdName=148664b9m55暂无昵称, createdTime=Thu Apr 22 13:09:31 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047329, encodeId=0539104e3291f, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Apr 21 21:09:19 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
    2021-04-22 148664b9m55暂无昵称

    学习学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1669068, encodeId=e17b16690689a, content=<a href='/topic/show?id=bc2114e79b8' target=_blank style='color:#2F92EE;'>#PRS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14779, encryptionId=bc2114e79b8, topicName=PRS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=209526497271, createdName=kzlchina, createdTime=Sun Jul 25 17:09:19 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012969, encodeId=3d871012969b8, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f1995401099, createdName=ms4000001617780766, createdTime=Mon Aug 30 19:57:19 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959367, encodeId=248295936e8b, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e95292076, createdName=148664b9m55暂无昵称, createdTime=Thu Apr 22 13:09:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959366, encodeId=4ebb959366f5, content=学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e95292076, createdName=148664b9m55暂无昵称, createdTime=Thu Apr 22 13:09:31 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047329, encodeId=0539104e3291f, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Apr 21 21:09:19 CST 2021, time=2021-04-21, status=1, ipAttribution=)]
    2021-04-21 CHANGE

    疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的

    0

相关资讯

脱发新疗法!FOL-005的II期临床研究已接近尾声

制药公司Follicum今天宣布,在正在进行的IIa期临床研究中,FOL-005治疗脱发的所有患者均已完成治疗,该研究在200多例名男性患者中检查了不同剂量的候选药物FOL-005的安全性和治疗效果。

Nature:慢性压力为何让人“头秃”

最近,为了了解连接系统性变化和干细胞行为的机制,研究人员探索慢性压力对毛囊干细胞的影响。

PNAS:中年爱脱发男性更自私、小气、不慷慨?

雄性激素,是指由性腺合成的一类内分泌激素,是维持正常性欲及生殖功能的激素,其中,由睾丸和肾上腺分泌的睾丸素(testosterone,也叫睾酮)是最重要的雄性激素。

Cell Metab :治疗脱发有望!谷氨酰胺代谢控制毛囊干细胞的可逆转化!

日常生活中,我们的皮肤和毛囊每天都会暴露在紫外线等环境之下,经历着损害、清除再更新生长的循环。每个人每天大约会流失5亿个细胞和100多根头发。

治疗脱发!礼来JAK抑制剂 III 期研究成功

礼来和 Incyte 联合宣布JAK抑制剂巴瑞替尼治疗成人重度斑秃(AA)的III期研究(BRAVE-AA2)达到积极顶线结果。两个剂量组巴瑞替尼 (2mg和4mg,每日1次)在第36周时均达到主要疗

拓展阅读

PRS:头发移植可以缩短长脸女性面部长度

长脸的形态与美学有关,既往常需要通过手术来纠正额面、上、中、下三分之一的面部过长影响。然而,仅仅在额面校正中线面部长度并不能提供面部和谐。

再生医学异军突起,植发不必再“拆东墙来补西墙”,平地也能起高楼了!

鉴于目前头发移植方法的基本局限性(即,供区头发数量有限,对脱发具有遗传抗性),以及脱发的心理后果被广泛低估,因此迫切需要更好的头发修复选择。

你脱发吗?拿什么拯救我们的头发?

雍禾医疗正式提交IPO招股书,拟于港交所上市,冲刺中国”植发第一股“

Aesthet Surg J:啥?胡须也能治疗秃头?

发表在Aesthetic Surgery Journal的研究称,胡须、躯干和四肢的体毛可以通过毛囊单位抽取技术(植发术)进行移植,改善患者的头皮和发际线。 Sanusi Umar博士对122例接受毛发移植治疗脱发的男性患者进行了研究,患者的平均年龄为42.7岁(范围24-66岁)。调查是通过发送给患者的电子邮件进行的,调查时间为2011年6月到2012年6月,评估捐赠者愈合、接受者生长和对